Top Markets
#1 DogBull DogBull +69.44%
#2 Siren Siren +31.70%
#3 OriginTrail OriginTrail +18.07%
#4 MarsCoin MarsCoin +9.72%
#5 Verus Coin Verus Coin +7.42%
#6 Falcon Finance Falcon Finance +6.32%
#7 RedStone RedStone +6.11%
#8 PulseChain PulseChain +6.04%
#9 Xphere Xphere +5.90%
#10 Concordium Concordium +5.69%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Charmacy Pharmaceutical Co., Ltd. Charmacy Pharmaceutical Co., Ltd.

Charmacy Pharmaceutical Co., Ltd.

2289
Rank in Stocks #22355
Charmacy Pharmaceutical Co., Ltd. serves as a prominent distributor of... Charmacy Pharmaceutical Co., Ltd. serves as a prominent distributor of pharmaceutical products across the People's Republic of China. The company's comprehensive portfolio includes Western medications, traditional Chinese patent medicines, and various healthcare items, along with associated advisory services. These are supplied to both wholesale distributors and retail pharmacies. Furthermore, Charmacy operates "Charmacy e-Medicine," its proprietary B2B digital platform, which enables clients to efficiently place orders, make inquiries, and process payments online. Founded in 1984, the firm maintains its headquarters in Shantou, PRC. It was formerly known as Chuangmei Pharmaceutical Co., Ltd. until its official renaming to Charmacy Pharmaceutical Co., Ltd. in July 2016.
Share Price
$0.8315205
Last synced: 2026-07-27
Market Cap
$89.79M
Change (1 day)
-4.41%
Change (1 year)
11.46%
Country
CN
Trade Charmacy Pharmaceutical Co., Ltd. (2289)

Category

Healthcare
Revenue for Charmacy Pharmaceutical Co., Ltd. (2289)
Revenue in Aug 2026 TTM: 0
According to Charmacy Pharmaceutical Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Charmacy Pharmaceutical Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
McKesson Corporation McKesson Corporation
McKesson Corporation
MCK.US
 $410.98B -
US
Cencora, Inc. Cencora, Inc.
Cencora, Inc.
COR.US
 - -
US
Cardinal Health, Inc. Cardinal Health, Inc.
Cardinal Health, Inc.
CAH.US
 $254.25B -
US
AmerisourceBergen Corporation AmerisourceBergen Corporation
AmerisourceBergen Corporation
ABC.US
 - -
US
Sigma Healthcare Limited Sigma Healthcare Limited
Sigma Healthcare Limited
SIG.AX
 $3.67B -
AU